↓ Skip to main content

Five Un-Easy Pieces of Pharmaceutical Policy Reform

Overview of attention for article published in Journal of Law, Medicine & Ethics, January 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 738)
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

blogs
3 blogs
policy
1 policy source

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Five Un-Easy Pieces of Pharmaceutical Policy Reform
Published in
Journal of Law, Medicine & Ethics, January 2021
DOI 10.1111/jlme.12067
Pubmed ID
Authors

Marc A. Rodwin

Abstract

Improper dependencies slant policy over a drug's life span, biasing the development of new drugs, the testing and marketing approval for new drugs, and the monitoring of patient safety after drugs are marketed. This article examines five ways in which the public improperly depends on pharmaceutical firms that compromise the integrity of pharmaceutical policy. Today the public relies on pharmaceutical firms: (1) to set priorities on drug research and development; (2) to conduct clinical trials to test whether drugs are safe and effective; (3) to decide what clinical trial data to disclose to the public; (4) to monitor post marketing drug safety; (5) to supply product information to physicians and to finance continuing medical education and other professional activities. The article suggests options to overcome each of these dependencies.

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 5%
Netherlands 1 5%
Belgium 1 5%
Unknown 17 85%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 35%
Student > Ph. D. Student 4 20%
Other 3 15%
Student > Bachelor 2 10%
Lecturer 1 5%
Other 2 10%
Unknown 1 5%
Readers by discipline Count As %
Social Sciences 9 45%
Medicine and Dentistry 5 25%
Agricultural and Biological Sciences 1 5%
Nursing and Health Professions 1 5%
Arts and Humanities 1 5%
Other 1 5%
Unknown 2 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2016.
All research outputs
#539,892
of 12,550,366 outputs
Outputs from Journal of Law, Medicine & Ethics
#34
of 738 outputs
Outputs of similar age
#10,216
of 191,684 outputs
Outputs of similar age from Journal of Law, Medicine & Ethics
#4
of 21 outputs
Altmetric has tracked 12,550,366 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 738 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,684 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.